Free Trial

Frontier Capital Management Co. LLC Acquires 663,018 Shares of Tempus AI, Inc. (NASDAQ:TEM)

Tempus AI logo with Medical background

Frontier Capital Management Co. LLC raised its holdings in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 236.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 943,718 shares of the company's stock after purchasing an additional 663,018 shares during the period. Frontier Capital Management Co. LLC owned approximately 0.60% of Tempus AI worth $31,860,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Circle Wealth Management LLC acquired a new position in shares of Tempus AI in the 4th quarter valued at approximately $253,000. Crestline Management LP acquired a new position in shares of Tempus AI in the 4th quarter valued at approximately $675,000. Brevan Howard Capital Management LP acquired a new position in shares of Tempus AI in the 4th quarter valued at approximately $682,000. Captrust Financial Advisors raised its position in shares of Tempus AI by 18.7% in the 4th quarter. Captrust Financial Advisors now owns 57,182 shares of the company's stock valued at $1,930,000 after buying an additional 9,012 shares in the last quarter. Finally, Balyasny Asset Management L.P. raised its position in shares of Tempus AI by 514.8% in the 4th quarter. Balyasny Asset Management L.P. now owns 41,501 shares of the company's stock valued at $1,401,000 after buying an additional 34,751 shares in the last quarter. Institutional investors own 24.22% of the company's stock.

Analyst Ratings Changes

A number of research firms recently issued reports on TEM. Piper Sandler lowered their price objective on shares of Tempus AI from $70.00 to $55.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. JPMorgan Chase & Co. cut shares of Tempus AI from an "overweight" rating to a "neutral" rating and upped their price objective for the stock from $50.00 to $55.00 in a research report on Tuesday, February 25th. Needham & Company LLC reiterated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research report on Wednesday. Bank of America upped their price objective on shares of Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. Finally, Guggenheim reiterated a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Six investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $61.50.

View Our Latest Stock Report on Tempus AI

Insider Transactions at Tempus AI

In related news, Director Nadja West sold 809 shares of the stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $51.11, for a total transaction of $41,347.99. Following the transaction, the director now directly owns 37,705 shares of the company's stock, valued at $1,927,102.55. This represents a 2.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Eric P. Lefkofsky sold 3,240,234 shares of the stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $58.75, for a total transaction of $190,363,747.50. Following the transaction, the chief executive officer now directly owns 4,895,589 shares in the company, valued at approximately $287,615,853.75. This represents a 39.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 4,237,561 shares of company stock worth $251,210,331 over the last three months. 27.60% of the stock is owned by company insiders.

Tempus AI Trading Down 5.9%

TEM traded down $3.88 during trading on Friday, reaching $61.34. 15,472,133 shares of the company's stock were exchanged, compared to its average volume of 6,015,116. The firm has a fifty day moving average price of $48.39 and a two-hundred day moving average price of $51.05. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $91.45. The stock has a market capitalization of $10.56 billion and a PE ratio of -7.86.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.03. The firm had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. The company's revenue was up 75.4% compared to the same quarter last year. As a group, equities research analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Tempus AI Profile

(Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Featured Articles

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

Should You Invest $1,000 in Tempus AI Right Now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines